Search results for "Papillary Cystadenocarcinoma"

showing 2 items of 2 documents

Mammary Analogue Secretory Carcinoma (MASC) of salivary gland in four Mexican patients.

2014

The Clinco-pathological, immunohistochemical and molecular findings of four cases of Mammary Analogue Secretory Carcinoma (MASC) of salivary glands found in Mexico are described. The cases were extracted from 253 salivary gland tumors from a single institution in Mexico City. The 85 candidates for initial selection were: low grade mucoepidermoid carcinoma (MEC) (N=70 ), acinic cell cancinoma (AciCC) (N=14), papillary cystadenocarcinoma (N=1), and adenocarcinoma NOS (N=0). Tumors with some histological features consistent with MASC (N= 17, 6.7%) were studied by immunohistochemistry for mammaglobin, STAT5, and S-100 protein and four cases were positive (1.5%), thus the diagnosis of MASC was e…

AdultMalePathologymedicine.medical_specialtyOdontologíaAcinic cell carcinomaMammaglobinPapillary CystadenocarcinomaMucoepidermoid carcinomaMajor Salivary GlandmedicineHumansMexicoGeneral DentistryLymph nodeRetrospective StudiesAged 80 and overOral Medicine and PathologybiologySalivary glandbusiness.industryResearchMiddle AgedSalivary Gland Neoplasms:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludmedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASbiology.proteinFemaleSurgeryMammary Analogue Secretory CarcinomabusinessSecretory Breast CarcinomaMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Characterization of a Human Carcinosarcoma Cell Line of the Ovary Established after in Vivo Change of Histologic Differentiation

2001

Abstract Objectives. Cell lines are valuable in vitro models for clinical and basic research. Most ovarian cancer cell lines described are serous cystadenocarcinomas or poorly differentiated adenocarcinomas. The establishment of ovarian cancer cell lines with rare histologic differentiation is especially of interest. We describe the establishment of a carcinosarcoma cell line of the ovary after in vivo selection. Methods. The cell line OV-MZ-22 was established from a solid tumor mass in the upper abdomen. At the time of establishment, the patient underwent secondary debulking and was pretreated with six cycles of cis -platinum/epirubicin/cyclophosphamide. Features of the cell line studied i…

Pathologymedicine.medical_specialtySerous cystadenocarcinomaCellular differentiationMice NudeBiologyMicePapillary CystadenocarcinomaCarcinosarcomaIntermediate Filament ProteinsCarcinosarcomaTumor Cells CulturedmedicineAnimalsHumansCystadenocarcinomaOvarian NeoplasmsObstetrics and GynecologyCell DifferentiationDNA NeoplasmMiddle Agedmedicine.diseaseDebulkingActinsOncologyKaryotypingCystadenocarcinoma PapillaryKeratinsAdenocarcinomaFemaleNeoplasm Recurrence LocalOvarian cancerNeoplasm TransplantationGynecologic Oncology
researchProduct